The association between circulating phenylalanine and the temporal risk of impaired insulin markers in gestational diabetes mellitus
- PMID: 38974841
- PMCID: PMC11227027
- DOI: 10.1016/j.ymgmr.2024.101090
The association between circulating phenylalanine and the temporal risk of impaired insulin markers in gestational diabetes mellitus
Abstract
Background: We aimed to contrast plasma amino acid concentrations in pregnant women with Gestational Diabetes Mellitus (GDM) to those without, to analyze the link between plasma amino acid concentrations, GDM, insulin resistance, and insulin secretion at 24-28 weeks of gestation.
Methods: The research employed a retrospective case-control study design at a single center. Basic demographic and laboratory data were procured from the hospital's case system. The study encompassed seventy women without gestational diabetes mellitus (GDM) and thirty-five women with GDM matched in a 1-to-2 ratio for age and pre-pregnancy BMI. Utilizing high-performance liquid chromatography-mass spectrometry (HPLC-MS), peripheral fasting plasma amino acid concentrations in these women, during mid-pregnancy, were duly measured. We carefully evaluated the significant differences in the quantitative data between the two groups and developed linear regression models to assess the independent risk factors affecting insulin resistance and insulin secretion.
Results: Significant variations in insulin secretion and resistance levels distinguished GDM Group from the non-GDM group at three distinct time points, alongside relatively elevated serum Glycosylated Hemoglobin (HbA1c) levels. Triglycerides (TG) were also significantly increased in those with GDM during adipocytokine observations. Apart from glutamic acid and glutamine, the concentrations of the remaining 16 amino acids were notably increased in GDM patients, including all branched chain amino acids(BCAAs) and aromatic amino acids(AAAs). Ultimately, it was ascertained that fasting serum phenylalanine levels were independent risk factors affecting insulin resistance index and insulin secretion at various phases.
Conclusions: Various fasting serum amino acid levels are markedly increased in patients with GDM, specifically phenylalanine, which may play role in insulin resistance and secretion.
Keywords: Aromatic amino acids; Gestational diabetes mellitus; Insulin resistance; Insulin secretion; Phenylalanine.
© 2024 Published by Elsevier Inc.
Conflict of interest statement
There is no dispute of mutual financial interests.
Figures
Similar articles
-
Branched-chain and aromatic amino acid levels response to an oral glucose load associated with gestational diabetes mellitus.Sci Rep. 2022 Jul 18;12(1):12257. doi: 10.1038/s41598-022-16539-y. Sci Rep. 2022. PMID: 35851317 Free PMC article.
-
Plasma levels of lysine, tyrosine, and valine during pregnancy are independent risk factors of insulin resistance and gestational diabetes.Metab Syndr Relat Disord. 2015 Mar;13(2):64-70. doi: 10.1089/met.2014.0113. Epub 2014 Nov 24. Metab Syndr Relat Disord. 2015. PMID: 25419905
-
Associations between insulin resistance and adverse pregnancy outcomes in women with gestational diabetes mellitus: a retrospective study.BMC Pregnancy Childbirth. 2021 Jul 23;21(1):526. doi: 10.1186/s12884-021-04006-x. BMC Pregnancy Childbirth. 2021. PMID: 34301212 Free PMC article.
-
Association of exposure to multiple heavy metals during pregnancy with the risk of gestational diabetes mellitus and insulin secretion phase after glucose stimulation.Environ Res. 2024 May 1;248:118237. doi: 10.1016/j.envres.2024.118237. Epub 2024 Jan 19. Environ Res. 2024. PMID: 38244971
-
Gestational diabetes mellitus and subsequent development of overt diabetes mellitus.Dan Med Bull. 1998 Nov;45(5):495-509. Dan Med Bull. 1998. PMID: 9850811 Review.
Cited by
-
Amelioration of cognition by hesperidin-conjugated cobalt oxide nanoparticles.Sci Rep. 2024 Dec 28;14(1):30748. doi: 10.1038/s41598-024-80320-6. Sci Rep. 2024. PMID: 39730537 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous